PLURYAL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Pluryal Volume
Pluryal Volume is a monophasic, highly cross-linked hyaluronic acid dermal filler from the Pluryal Fillers Essentials range, manufactured by MD Skin Solutions Laboratoires in Luxembourg. It is formulated at 2.3% (23 mg/mL) hyaluronic acid obtained from Streptococcus equi bacteria and cross-linked with BDDE to a residual level of ≤ 2 ppm in a phosphate buffer with NaCl, and carries an elastic modulus (G’) of 400,000 mPa. It is indicated for correcting deeper wrinkles and folds, increasing or restoring volume to the face and remodelling facial contours, and can also address medical reconstructive purposes such as facial lipoatrophy, debilitating scars and morphological asymmetry. Supplied in a 1 mL syringe and injected into the deep dermis or subcutis, it is repeated every 9-12 months or as required. Pluryal Volume does not contain lidocaine and is a distinct product from Pluryal Volume Lidocaine, which adds 0.3% lidocaine hydrochloride for injection comfort. It is a class III medical device for professional use only.
Key Benefits of Pluryal Volume
- Highly cross-linked hyaluronic acid at 2.3% (23 mg/mL) with a G’ of 400,000 mPa
- Corrects deeper wrinkles and folds, restores facial volume and remodels facial contours
- Non-inferior to a reference hyaluronic acid filler in a prospective, split-face, randomised, evaluator- and subject-blinded multicentre trial
- 97.9% GAIS improvement in nasolabial fold appearance at day 270 in a published 48-patient study
- Long treatment interval: every 9-12 months or as required
- Monophasic and particle-free for uniform degradation without over-correction; isotonic for improved comfort during treatment
- Extrusion force of 12 N, tested on every batch
Indications and Professional Use
Main indications
- Correction of deeper wrinkles and folds
- Increase or restoration of facial volume
- Remodelling of facial contours
- Cosmetic and medical reconstructive treatment of facial lipoatrophy, debilitating scars and morphological asymmetry
Professional use
Pluryal Volume is a class III medical device, to be used only by doctors who have received specific training on intradermal injection techniques. Composition and specification: cross-linked hyaluronic acid 2.3% (23 mg/mL) obtained from Streptococcus equi, phosphate buffer, NaCl; BDDE cross-linked (≤ 2 ppm); molecular weight 3 million Da; G’ 400,000 mPa; extrusion force 12 N; endotoxins < 0.5 EU/mL; steam sterilized. Level of injection: deep dermis or subcutis. Treatment frequency: every 9-12 months or as required.
Treatment areas
- Nasolabial folds
- Jawline
- Glabellar lines
- Bitterness lines
- Cheeks
Patient profile
Adult patients presenting deeper wrinkles and folds, or requiring restoration of facial volume and remodelling of facial contours, as assessed by the treating doctor. The device can also address medical reconstructive purposes such as facial lipoatrophy, debilitating scars or morphological asymmetry. Pluryal Volume is a class III medical device restricted to doctors trained in intradermal injection techniques, and patients must be informed about possible side effects.
How Pluryal Volume Works
Pluryal Volume works through a monophasic, highly cross-linked hyaluronic acid gel at 2.3% (23 mg/mL), obtained from Streptococcus equi bacteria and cross-linked with BDDE to a residual level of ≤ 2 ppm, in a phosphate buffer with NaCl.
Built on Pluryal’s P.R.E.M.I.U.M. technology, it carries a high elastic modulus (G’ 400,000 mPa) — the rheological parameter that governs a gel’s filling effect and its retention time in soft tissue — which is what allows it to restore volume and remodel facial contours when injected into the deep dermis or subcutis. Being monophasic and free from particles, the gel degrades uniformly without the need to over-correct and keeps a smooth, natural feel to the touch and sight, and it is isotonic, with pH and osmolarity adjusted to physiological conditions for improved comfort during treatment.
Why Order From Allpara
Allpara offers genuine, verified PLURYAL products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Is Pluryal Volume suitable for the cheeks?
Yes. Pluryal Volume is indicated to increase or restore volume to the face and to remodel facial contours, and the cheeks are among the target areas of the Pluryal Fillers Essentials range.
Is Pluryal Volume the same as Pluryal Volume Lidocaine?
No. Pluryal Volume does not contain lidocaine. Pluryal Volume Lidocaine is a separate, distinct product with added anaesthetic for injection comfort.
How much hyaluronic acid does the Pluryal Volume hyaluronic dermal filler contain?
Pluryal Volume contains cross-linked hyaluronic acid at 2.3% (23 mg/mL).
More from MD Skin solutions Laboratoires
Clinic alternatives
Pick up where you left off
Pluryal Volume
Pluryal Volume is a monophasic, highly cross-linked hyaluronic acid dermal filler from the Pluryal Fillers Essentials range, manufactured by MD Skin Solutions Laboratoires in Luxembourg. It is formulated at 2.3% (23 mg/mL) hyaluronic acid obtained from Streptococcus equi bacteria and cross-linked with BDDE to a residual level of ≤ 2 ppm in a phosphate buffer with NaCl, and carries an elastic modulus (G’) of 400,000 mPa. It is indicated for correcting deeper wrinkles and folds, increasing or restoring volume to the face and remodelling facial contours, and can also address medical reconstructive purposes such as facial lipoatrophy, debilitating scars and morphological asymmetry. Supplied in a 1 mL syringe and injected into the deep dermis or subcutis, it is repeated every 9-12 months or as required. Pluryal Volume does not contain lidocaine and is a distinct product from Pluryal Volume Lidocaine, which adds 0.3% lidocaine hydrochloride for injection comfort. It is a class III medical device for professional use only.
Key Benefits of Pluryal Volume
- Highly cross-linked hyaluronic acid at 2.3% (23 mg/mL) with a G’ of 400,000 mPa
- Corrects deeper wrinkles and folds, restores facial volume and remodels facial contours
- Non-inferior to a reference hyaluronic acid filler in a prospective, split-face, randomised, evaluator- and subject-blinded multicentre trial
- 97.9% GAIS improvement in nasolabial fold appearance at day 270 in a published 48-patient study
- Long treatment interval: every 9-12 months or as required
- Monophasic and particle-free for uniform degradation without over-correction; isotonic for improved comfort during treatment
- Extrusion force of 12 N, tested on every batch
Indications and Professional Use
Main indications
- Correction of deeper wrinkles and folds
- Increase or restoration of facial volume
- Remodelling of facial contours
- Cosmetic and medical reconstructive treatment of facial lipoatrophy, debilitating scars and morphological asymmetry
Professional use
Pluryal Volume is a class III medical device, to be used only by doctors who have received specific training on intradermal injection techniques. Composition and specification: cross-linked hyaluronic acid 2.3% (23 mg/mL) obtained from Streptococcus equi, phosphate buffer, NaCl; BDDE cross-linked (≤ 2 ppm); molecular weight 3 million Da; G’ 400,000 mPa; extrusion force 12 N; endotoxins < 0.5 EU/mL; steam sterilized. Level of injection: deep dermis or subcutis. Treatment frequency: every 9-12 months or as required.
Treatment areas
- Nasolabial folds
- Jawline
- Glabellar lines
- Bitterness lines
- Cheeks
Patient profile
Adult patients presenting deeper wrinkles and folds, or requiring restoration of facial volume and remodelling of facial contours, as assessed by the treating doctor. The device can also address medical reconstructive purposes such as facial lipoatrophy, debilitating scars or morphological asymmetry. Pluryal Volume is a class III medical device restricted to doctors trained in intradermal injection techniques, and patients must be informed about possible side effects.
How Pluryal Volume Works
Pluryal Volume works through a monophasic, highly cross-linked hyaluronic acid gel at 2.3% (23 mg/mL), obtained from Streptococcus equi bacteria and cross-linked with BDDE to a residual level of ≤ 2 ppm, in a phosphate buffer with NaCl.
Built on Pluryal’s P.R.E.M.I.U.M. technology, it carries a high elastic modulus (G’ 400,000 mPa) — the rheological parameter that governs a gel’s filling effect and its retention time in soft tissue — which is what allows it to restore volume and remodel facial contours when injected into the deep dermis or subcutis. Being monophasic and free from particles, the gel degrades uniformly without the need to over-correct and keeps a smooth, natural feel to the touch and sight, and it is isotonic, with pH and osmolarity adjusted to physiological conditions for improved comfort during treatment.
Why Order From Allpara
Allpara offers genuine, verified PLURYAL products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Is Pluryal Volume suitable for the cheeks?
Yes. Pluryal Volume is indicated to increase or restore volume to the face and to remodel facial contours, and the cheeks are among the target areas of the Pluryal Fillers Essentials range.
Is Pluryal Volume the same as Pluryal Volume Lidocaine?
No. Pluryal Volume does not contain lidocaine. Pluryal Volume Lidocaine is a separate, distinct product with added anaesthetic for injection comfort.
How much hyaluronic acid does the Pluryal Volume hyaluronic dermal filler contain?
Pluryal Volume contains cross-linked hyaluronic acid at 2.3% (23 mg/mL).